These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 8690730

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prevention of liver fibrosis and liver reconstitution of DMN-treated rat liver by transplanted EPCs.
    Nakamura T, Torimura T, Iwamoto H, Masuda H, Naitou M, Koga H, Abe M, Hashimoto O, Tsutsumi V, Ueno T, Sata M.
    Eur J Clin Invest; 2012 Jul; 42(7):717-28. PubMed ID: 22224757
    [Abstract] [Full Text] [Related]

  • 24. Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury.
    Fan J, Li X, Li P, Li N, Wang T, Shen H, Siow Y, Choy P, Gong Y.
    Biochem Cell Biol; 2007 Apr; 85(2):189-95. PubMed ID: 17534399
    [Abstract] [Full Text] [Related]

  • 25. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
    Kuriyama S, Yokoyama F, Inoue H, Takano J, Ogawa M, Kita Y, Yoshiji H, Deguchi A, Kimura Y, Himoto T, Yoneyama H, Kurokohchi K, Masaki T, Uchida N, Watanabe S.
    Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
    [Abstract] [Full Text] [Related]

  • 26. Treating liver cirrhosis in dogs with hepatocyte growth factor gene therapy via the hepatic artery.
    Horiguchi K, Hirano T, Ueki T, Hirakawa K, Fujimoto J.
    J Hepatobiliary Pancreat Surg; 2009 Feb; 16(2):171-7. PubMed ID: 19221688
    [Abstract] [Full Text] [Related]

  • 27. A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor.
    Oe S, Fukunaka Y, Hirose T, Yamaoka Y, Tabata Y.
    J Control Release; 2003 Mar 07; 88(2):193-200. PubMed ID: 12628327
    [Abstract] [Full Text] [Related]

  • 28. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
    Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, Rosmorduc O.
    Am J Pathol; 2002 Feb 07; 160(2):613-20. PubMed ID: 11839582
    [Abstract] [Full Text] [Related]

  • 29. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice.
    Kosai K, Matsumoto K, Funakoshi H, Nakamura T.
    Hepatology; 1999 Jul 07; 30(1):151-9. PubMed ID: 10385651
    [Abstract] [Full Text] [Related]

  • 30. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
    Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamura T, Takei Y, Sato N.
    J Hepatol; 2007 Feb 07; 46(2):286-94. PubMed ID: 17166617
    [Abstract] [Full Text] [Related]

  • 31. Increased technetium-99m-GSA uptake per hepatocyte in rats with administration of dimethylnitrosamine or hepatocyte growth factor.
    Kouda K, Ha-Kawa SK, Tanaka Y.
    J Nucl Med; 1998 Aug 07; 39(8):1463-7. PubMed ID: 9708531
    [Abstract] [Full Text] [Related]

  • 32. Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7.
    Inagaki Y, Higashi K, Kushida M, Hong YY, Nakao S, Higashiyama R, Moro T, Itoh J, Mikami T, Kimura T, Shiota G, Kuwabara I, Okazaki I.
    Gastroenterology; 2008 Apr 07; 134(4):1180-90. PubMed ID: 18395096
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats.
    Oe H, Kaido T, Mori A, Onodera H, Imamura M.
    Hepatogastroenterology; 2005 Apr 07; 52(65):1393-7. PubMed ID: 16201081
    [Abstract] [Full Text] [Related]

  • 36. Protective effect of theaflavin-enriched black tea extracts against dimethylnitrosamine-induced liver fibrosis in rats.
    Weerawatanakorn M, Lee YL, Tsai CY, Lai CS, Wan X, Ho CT, Li S, Pan MH.
    Food Funct; 2015 Jun 07; 6(6):1832-40. PubMed ID: 25927469
    [Abstract] [Full Text] [Related]

  • 37. The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats.
    Lee ES, Lee HE, Shin JY, Yoon S, Moon JO.
    J Pharm Pharmacol; 2003 Aug 07; 55(8):1169-74. PubMed ID: 12956909
    [Abstract] [Full Text] [Related]

  • 38. Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats.
    Cheong KO, Shin DS, Bak J, Lee C, Kim KW, Je NK, Chung HY, Yoon S, Moon JO.
    Arch Pharm Res; 2016 Feb 07; 39(2):279-291. PubMed ID: 26667466
    [Abstract] [Full Text] [Related]

  • 39. HGF: its organotrophic role and therapeutic potential.
    Matsumoto K, Nakamura T.
    Ciba Found Symp; 1997 Feb 07; 212():198-211; discussion 211-4. PubMed ID: 9524772
    [Abstract] [Full Text] [Related]

  • 40. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
    Yue HY, Yin C, Hou JL, Zeng X, Chen YX, Zhong W, Hu PF, Deng X, Tan YX, Zhang JP, Ning BF, Shi J, Zhang X, Wang HY, Lin Y, Xie WF.
    Gut; 2010 Feb 07; 59(2):236-46. PubMed ID: 19671543
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.